Carriers at higher risk of developing neurodegenerative disease
A team of Canadian scientists, including researchers at the Montreal Neurological Institute and Hospital (The Neuro) has discovered the first French-Canadian founder mutation gene linked to synucleinopathies, a group of neurodegenerative diseases that includes Parkinson鈥檚 disease (PD), dementia with Lewy-Bodies (DLB) and multiple system atrophy (MSA).
When it comes to weight gain, the problem may be mostly in our heads, and our genes
Clinicians should consider how the way we think can make us vulnerable to obesity, and how obesity is genetically intertwined with brain structure and mental performance, according to new research.
A look at the latest ALS research and clinical care at The Neuro
Amyotrophic lateral sclerosis (ALS) is a terrible disease with no known cure. Research at The Montreal Neurological Institute and Hospital (The Neuro) is uncovering data that could help find effective treatments for ALS.听
听
听
For someone with Parkinson鈥檚 disease (PD), the simple desire to grasp a glass of water can become an insurmountable task, made impossible by the tremors in their hand or arm. Finding strategies to improve these movement impairments is one of the major goals of rehabilitating people with Parkinson鈥檚 disease.
At 香蕉视频, Dr. Marc Roig, an assistant professor in the School of Physical and Occupational Therapy (SPOT), is studying the effects of using high-intensity exercise to stimulate the brain鈥檚 ability to learn and change with repeated experiences.
On April 20, 2018, Canadian, Chinese and Cuban neuroscience institutes strengthened an existing partnership with the signing of a memorandum of understanding in Chengdu, China.
Partners in the agreement include The Montreal Neurological Institute and Hospital (The Neuro) of 香蕉视频, The Cuban Neuroscience Center, The University of Electronic Sciences and Technology of China, The West China Hospital, and The Tianfu New Area of Chengdu (TFNA).
The Neuro is recognized worldwide as a leader in epilepsy research and treatment. From the beginning, Neuro founder, Dr. Wilder Penfield, made epilepsy a central focus. He and his colleagues developed a surgical treatment for epilepsy patients known as the 鈥淢ontreal Procedure,鈥� which today is in use throughout the world. The Neuro became a pioneer in studying epilepsy through the use of electroencephalography (EEG) and magnetic resonance imaging (MRI).
The Healthy Brains for Healthy Lives (HBHL) initiative is happy to announce the launch of its Neuro-Innovation Fund. HBHL鈥檚 Neuro-Innovation Fund aims to close the gap between proof-of-concept research grants, and funding from traditional investors (angels, venture capitalist, institutional investors). The Fund will provide technology development grants to support further proof of principle and/or add value to new technologies or inventions related to the research themes of HBHL.
Qu茅bec Science magazine鈥檚 25-year tradition continues: every fall, a jury comprised of researchers and journalists selects the top 10 most impressive discoveries in Quebec in the past year and the public is asked to vote to select the winner. This year, a cancer-detection probe was chosen by nearly a third of approximately 4,400 votes cast in the 2017 Discovery of the Year contest.
听
The Neuro has launched Neuro XXceptional - an exciting new year-long video series featuring women who tell us what drove them to become scientists and clinicians, and what they love about their work. At The Neuro, these exceptional professionals are improving the lives of patients, helping us understand how the brain works and how to treat neurological disease.
Healthy Brains for Healthy Lives (HBHL) is a high profile, high priority multidisciplinary and cross-sectoral initiative located at 香蕉视频 made possible with support from the Canada First Research Excellence Fund (). The HBHL Strategic Research Plan outlines the vision, deliverables, and overall goals of the initiative, and the research priorities of its four research themes.
Industry and academia to share expertise in effort to develop improved methods to produce and characterize antibodies and reagents for neurological research
You鈥檙e about to turn 60, and you鈥檙e fretting. Your mother has had Alzheimer鈥檚 disease since the age of 65. At what age will the disease strike you? A Canadian study published in JAMA Neurology shows that the closer a person gets to the age at which their parent exhibited the first signs of Alzheimer鈥檚, the more likely they are to have amyloid plaques, the cause of the cognitive decline associated with the disease, in their brain.
The HCALM Network issues regularly a call for proposals for research projects whose focus is to investigate the relationship between language and access to health care or social services.
Proposals must be e-mailed by Sunday, April 8, 2018.
For all information, click here.
's investment of $150 million in 香蕉视频's Healthy Brains for Healthy Lives (HBHL) and Western University's marks a pivotal step that will unlock the mysteries of the human mind and lay the groundwork for a pan-Canadian network of collaboration that promises to uncover new ways to treat, prevent and cure brain disorders.听
